대장균 균주 시장 : 균주 유형별, 용도별, 병원성별, 최종사용자별, 지역별

Escherichia Coli Strain Market, By Strain Type, By Application, By Pathogenicity, By End User, By Geography

US $ 4,500 ￦ 6,310,000

Unprintable PDF & Excel (Single User License)

US $ 7,000 ￦ 9,816,000

PDF & Excel (Multi User License - Up to 7 Users)

US $ 10,000 ￦ 14,024,000

PDF & Excel (Corporate User License)

한글목차

대장균 균주 시장 규모는 2025년에 22억 6,000만 달러, 2032년에는 36억 1,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 6.9%를 나타낼 전망입니다.

분석 범위		분석 상세
기준 연도	2024년	시장 규모(2025년)	22억 6,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 CAGR(2025-2032년)	6.90%	예측 금액(2032년)	36억 1,000만 달러

일반적으로 대장균으로 알려진 대장균은 다양한 특성과 연구에서의 광범위한 사용으로 인해 과학적으로 큰 관심을 받고 있는 박테리아 균주입니다. 이 박테리아는 장내 세균과에 속하며 일반적으로 인간과 동물의 소화관에 존재합니다. 대장균은 종종 식중독 및 감염과 관련이 있지만 모든 균주가 유해한 것은 아니라는 점에 유의하는 것이 중요합니다. 실제로 많은 균주는 유익하고 소화기관에서 중요한 역할을 하며 음식물의 분해와 영양소 흡수를 돕습니다. 그러나 병원성을 가진 대장균도 존재하며, 경미한 위장 장애부터 요로 감염, 폐렴, 심지어 생명을 위협하는 용혈성 요독증 증후군과 같은 심각한 증상까지 다양한 질병을 유발할 수 있습니다. 이러한 대장균의 광범위한 질병을 유발하는 능력으로 인해 대장균은 공중보건학적으로 중요한 관심사가 되고 있습니다. 대장균의 다양한 특성과 건강과 질병에 대한 역할로 인해 대장균은 과학 연구에 매우 중요한 모델 생물입니다. 대장균은 유전학, 생화학, 생명공학 분야에서 광범위하게 연구되고 있으며, 이들 분야의 이해에 크게 기여하고 있습니다. 연구자들은 대장균을 이용하여 박테리아의 유전학 연구, 대사경로 조사, 새로운 생명공학 응용을 개발하고 있습니다. 이러한 광범위한 조사는 대장균 자체에 대한 지식을 심화시킬 뿐만 아니라 보다 광범위한 생물학적 과정에 대한 귀중한 통찰력을 제공합니다.

시장 역학:

생명공학 연구, 재조합 단백질 생산, 의약품 개발은 예측 기간 동안 세계 대장균 균주 시장의 성장을 견인할 것으로 예측됩니다. 또한, 산업 공정도 예측 기간 동안 세계 대장균 균주 시장의 성장을 가속할 것으로 예측됩니다. 바이오 의약품 생산, 합성 생물학, 개인 맞춤형 의료, 생물학적 치료는 예측 기간 동안 세계 대장균 시장에 성장 기회를 제공할 것으로 예측됩니다.

그러나 안전 및 바이오 보안에 대한 우려, 규제 장애물, 다른 미생물과의 경쟁, 오염 및 교차 오염의 위험은 예측 기간 동안 대장균 균주 시장의 성장을 저해할 것으로 예측됩니다.

본 보고서의 주요 특징

• 세계의 대장균 균주 시장을 상세하게 분석하고, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 CAGR을 조사하여 전해드립니다.
• 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 세계 대장균 균주 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 정리하여 수록하였습니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• "대장균 균주 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 대장균 균주 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 분석 목적과 전제조건

• 분석 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
• 영향 분석
• 성장 억제요인
• 기회
• 주요 하이라이트
• 규제 시나리오
• 제품 발매 및 승인
• PEST 분석
• Porter의 Five Forces 분석
• 인수합병(M&A)·제휴 분석

제4장 대장균 균주 시장 : 신형 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 대장균 균주 시장 : 균주 유형별(2020-2032년)

• 공생 균주
• 설사성 균주
• 장관외 병원성 균주
• 요로 병원성 균주
• 신생아 수막염 균주
• 기타

제6장 대장균 균주 시장 : 용도별(2020-2032년)

• 진단
• 연구
• 치료제
• 재조합 단백질 생산
• 품질 관리 생물
• 기타

제7장 대장균 균주 시장 : 병원성별(2020-2032년)

• 병원성 대장균
• 비병원성 대장균

제8장 대장균 균주 시장 : 최종사용자별(2020-2032년)

• 연구기관
• 진단실험실
• 제약 기업 및 바이오테크놀러지 기업
• CRO(의약품 임상시험수탁기관)
• 기타

제9장 대장균 균주 시장 : 지역별(2020-2032년)

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제10장 경쟁 구도

• 기업 개요
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Novozymes A/S
  • QIAGEN NV
  • Promega Corporation
  • Agilent Technologies, Inc.
  • New England Biolabs, Inc.
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Sanofi
  • Xiamen Innovax Biotech Co., Ltd

제11장 섹션

• 참고 문헌
• 조사 방법
• 출판사에 대해

LSH

영문 목차

영문목차

Escherichia Coli Strain Market is estimated to be valued at USD 2.26 Bn in 2025 and is expected to reach USD 3.61 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 2.26 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.90%	2032 Value Projection:	USD 3.61 Bn

Escherichia Coli, commonly known as E. coli, is a strain of bacteria that has garnered significant scientific interest due to its diverse nature and extensive use in research. This bacterium belongs to the Enterobacteriaceae family and is typically found in the gastrointestinal tract of humans and animals. While E. coli is often associated with foodborne illnesses and infections, it's important to note that not all strains are harmful. In fact, many strains are beneficial and play a crucial role in the digestive system, aiding in the breakdown of food and absorption of nutrients. These beneficial strains also help in maintaining a healthy gut flora, which is essential for overall health.However, there are certain strains of E. coli that are pathogenic and can cause a range of illnesses, from minor gastrointestinal upset to severe conditions like urinary tract infections, pneumonia, and even life-threatening hemolytic uremic syndrome. The ability of E. coli to cause such a wide spectrum of diseases makes it a significant public health concern. E. coli's versatile nature and its role in both health and disease have made it a crucial model organism for scientific research. It is extensively studied in the fields of genetics, biochemistry, and biotechnology, contributing significantly to our understanding of these areas. Researchers use E. coli to study bacterial genetics, investigate metabolic pathways, and develop new biotechnological applications. This extensive research has not only enhanced our knowledge of E. coli itself but also provided valuable insights into broader biological processes.

Market Dynamics:

Biotechnology research, recombinant protein production and pharmaceutical development are anticipated to drive the growth of the global escherichia coli strain market over the forecast period. Moreover, industrial processes are also expected to boost the growth of the global escherichia coli strain market over the forecast period. Biopharmaceutical production, synthetic biology, personalized medicine, and bioremediation are expected to create growth opportunities for the global Escherichia Coli Strain market during the forecast period.

However, safety and biosecurity concerns, regulatory hurdles, competition from other microorganisms and contamination and cross-contamination risks are expected to hamper growth of the escherichia coli strain market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global escherichia coli strain market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global escherichia coli strain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Sanofi, and Xiamen Innovax Biotech Co., Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global escherichia coli strain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global escherichia coli strain market

Detailed Segmentation:

• Escherichia Coli Strain Market, By Strain Type:
  • Commensal strains
  • Diarrheal strains
  • Extraintestinal pathogenic strains
  • Uropathogenic strains
  • Neonatal meningitis strains
  • Others
• Escherichia Coli Strain Market, By Application:
  • Diagnostics
  • Research
  • Therapeutics
  • Production of recombinant proteins
  • Quality control organisms
  • Others
• Escherichia Coli Strain Market, By Pathogenicity:
  • Pathogenic E. coli
  • Non-pathogenic E. coli
• Escherichia Coli Strain Market, By End User:
  • Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Others
• Escherichia Coli Strain Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Novozymes A/S
  • QIAGEN N.V.
  • Promega Corporation
  • Agilent Technologies, Inc.
  • New England Biolabs, Inc.
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Sanofi
  • Xiamen Innovax Biotech Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Strain Type
  • Market Snippet, By Application
  • Market Snippet, By Pathogenicity
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Biotechnology research is expected to drive the market growth over forecast period
  • Restraints
• Safety and biosecurity concerns is expected to hinder the market growth over forecast period
  • Opportunities
• Personalized medicine to provide custom-made E. coli strains for precision medicine applications is expected to provide market opportunity
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Escherichia Coli Strain Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Escherichia Coli Strain Market, By Strain Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Commensal strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diarrheal strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Extraintestinal pathogenic strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Uropathogenic strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neonatal meningitis strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Escherichia Coli Strain Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Production of recombinant proteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Quality control organisms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Escherichia Coli Strain Market, By Pathogenicity, 20218-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%) Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pathogenic E. coli
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Non-pathogenic E. coli
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Escherichia Coli Strain Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Escherichia Coli Strain Market, By Geography, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Thermo Fisher Scientific Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Merck KGaA
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Novozymes A/S
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • QIAGEN N.V.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Promega Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Agilent Technologies, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • New England Biolabs, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Takara Bio Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Bio-Rad Laboratories, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • GenScript Biotech Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Sanofi
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Xiamen Innovax Biotech Co., Ltd
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

11. Section

• References
• Research Methodology
• About us

관련자료